A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sulfadoxine
Benactyzine
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Benactyzine.
Sulfadoxine
Benzoctamine
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Benzoctamine.
Sulfadoxine
Brotizolam
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Brotizolam.
Sulfadoxine
Butriptyline
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Butriptyline.
Sulfadoxine
Captodiame
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Captodiame.
Sulfadoxine
Beclamide
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Beclamide.
Sulfadoxine
Cyamemazine
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Cyamemazine.
Sulfadoxine
Eperisone
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Eperisone.
Sulfadoxine
Etifoxine
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Etifoxine.
Sulfadoxine
Hexamethonium
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Hexamethonium.
Sulfadoxine
Ifenprodil
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Ifenprodil.
Sulfadoxine
Amperozide
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Amperozide.
Sulfadoxine
Perospirone
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Perospirone.
Sulfadoxine
Cinitapride
The risk or severity of adverse effects can be increased when Cinitapride is combined with Pomalidomide.
Sulfadoxine
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of adverse effects can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Pomalidomide.
Sulfadoxine
Sulthiame
The risk or severity of adverse effects can be increased when Sulthiame is combined with Pomalidomide.
Sulfadoxine
Mebutamate
The risk or severity of adverse effects can be increased when Mebutamate is combined with Pomalidomide.
Sulfadoxine
Triclofos
The risk or severity of adverse effects can be increased when Triclofos is combined with Pomalidomide.
Sulfadoxine
Ketobemidone
The risk or severity of adverse effects can be increased when Ketobemidone is combined with Pomalidomide.
Sulfadoxine
Fospropofol
The risk or severity of adverse effects can be increased when Fospropofol is combined with Pomalidomide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3